Key result
Genomic analysis of EV-A71 reveals extensive recombination and 11 EV-A71-like signatures in cocirculating viruses worldwide.
Why the study?
How newly emerging recombinant EV-A71 strains arose within a short period of time remained unknown.
Identification of specific recombination patterns and 11 EV-A71-like signatures in circulating Enterovirus A viruses suggests potential targets for wide-spectrum antiviral development.
May guide antiviral targets against cocirculating EV-A; leaves open validation in clinical or surveillance studies.
Enterovirus A71 (EV-A71) is an important nonpolio enterovirus that causes severe neurological complications. In 1998, Taiwan experienced an EV-A71 outbreak that caused 78 deaths. Since then, periodic epidemics of EV-A71 associated with newly emerging strains have occurred. Several of these strains are known to be recombinant; however, how these strains arose within such a short period of time remains unknown. Here, we sequenced 64 full-length genomes from clinical isolates collected from 2005 to 2016 and incorporated all 91 Taiwanese genomes downloaded from the Virus Pathogen Resource to extensively analyze EV-A71 recombination in Taiwan. We found that the B3 subgenotype was a potential recombinant parent of the EV-A71 C2-like and C4 strains by intratypic recombination. Such B3-similar regions were also found in many cocirculating coxsackieviruses belonging to Enterovirus A species (EV-A) through a series of intertypic recombinations. Therefore, locally enriched outbreaks of cocirculating viruses from different genotypes/serotypes may facilitate recombination. Most recombination breakpoints we found had nonrandom distributions and were located within the region spanning from the boundary of P1 (structural gene) and P2 (nonstructural) to the cis-Acting replication element at P2, indicating that specific genome reassembly of structural and nonstructural genes may be subject to natural selection. Through intensive recombination, 11 EV-A71-like signatures (including one in 3A, two in 3C, and eight in 3D) were found to be present in a variety of recently cocirculating EV-A viruses worldwide, suggesting that these viruses may be targets for wide-spectrum antiviral development.
No takes yet. Share an insight, caveat, or question.
Woodman et al. (2020) studied Enterovirus A71 (n=155). Genomic sequencing and recombination analysis was evaluated on Recombination breakpoints and EV-A71-like signatures. Genomic analysis of 155 EV-A71 genomes revealed extensive recombination and identified 11 EV-A71-like signatures in recently cocirculating EV-A viruses worldwide.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: